Please see recent Pharmacopeial Discussion Group Working Procedures Changes here effective April 1, 2018.
USP versions of Stage 4 Harmonization includes monographs or general chapters that have completed stages 1-5 of the five-stage PDG pharmacopeial harmonization process resulting in an approved USP–NF text. Stage 4 adopted text is published here so that USP–NF users may become aware of its availability as a pharmacopeial standard and its targeted official date. See chart below for specific posting and official dates.
|Month||Posting Date on USP-NF.com||Incorporated in to Print Publication||Official Date|
|Apr 2019||Apr 26, 2019||USP 43-NF 38||May 1, 2020|
|Sep 2019||Sep 27, 2019||N/A*||Aug 1, 2020|
|Nov 2019||Nov 22, 2019||N/A*||Dec 1, 2020|
|Feb 2020||Feb 28, 2020||N/A*||May 1, 2021|
|Apr 2020||Apr 24, 2020||N/A*||May 1, 2021|
|Sep 2020||Sep 25, 2020||N/A*||Aug 1, 2021|
|Nov 2020||Nov 20, 2020||N/A*||Dec 1, 2021|
|Feb 2021||Feb 26, 2021||N/A*||May 1, 2022|
* As of First Supplement to USP 43– NF 38, USP no longer prints a publication and standards are posted regularly on USP–NF Online. Please see this Notice for more information.
New Stage 4 Notice
- Copovidone (posted 24-Apr-2020**; official 01-May-2021)
- Sodium Lauryl Sulfate (posted 24-Apr-2020**; official 01-May-2021)
- Conductivity (posted 24-Apr-2020**; official 01-May-2021)
- Capillary Electrophoresis (posted 27-Sep-2019; official 01-Aug-2020) | En español
- Hydroxyethyl Cellulose (posted 27-Sep-2019; official 01-Aug-2020) | En español
View harmonization status for:
** Posted date corrected on May 11, 2020